Abstract 3179: Design and activity of 2<sup>nd</sup>generation, dual-targeted CAR T cell factories against ccRCC
Yufei Wang(Fujian Medical University), Wayne A. Marasco(Dana-Farber Cancer Institute), Rebecca B. Jennings(IHS Markit (United States)), Quan Zhu(Dana-Farber Cancer Institute), Matthew Chang(Dana-Farber Cancer Institute), Eloah Rabello Suarez(Dana-Farber Cancer Institute), Sabina Signoretti(Brigham and Women's Hospital)
Cited by 0
Related Papers
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
|Nature Medicine|2020|1k
High-throughput oncogene mutation profiling in human cancer
|Nature Genetics|2007|996
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
|Cell Reports|2018|818
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
|Nature Genetics|2018|701